IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex reports fall in profits

12:28 AM MST | November 6, 2012 | Deepti Ramesh

Cambrex (East Rutherford, NJ) reported a 39% fall in net profits for the third quarter, ended 30 September 2012, compared with the year-ago period, to $1.68 million. Net sales increased 2.7%, to $59.4 million, primarily because of higher custom development revenues and higher volumes of generic active pharmaceutical ingredients (APIs) partially offset by lower pricing, Cambrex says. “We had a strong quarter as sales increased across virtually all of our product categories, with record quarterly cash flow, and excellent working capital results,” says...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa